Skip to main content
IMCR logo

IMCR · Immunocore Holdings plc · Executive Compensation

Track IMCR — free
$26.41 -0.22 (-0.83%) At close · Nov 20 Q4 2025 earnings call transcript
Market Cap
$1.36B
Shares
51.68M
Volume · Nov 20 546.2K Avg daily vol (3M) 449.07K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Bahija Jallal $10,885,268
Travis Coy $5,171,209
David Berman $4,278,988
Tina St. Leger $1,204,261
Fiscal 2024
Executive Total
Bahija Jallal $12,852,234
David Berman $5,481,495
Brian Di Donato $3,439,339
Tina St. Leger $1,115,871
Fiscal 2023
Executive Total
Bahija Jallal $11,678,834
David Berman $4,396,622
Brian Di Donato $3,354,443
Tina St. Leger $1,039,117
Fiscal 2022
Executive Total
Bahija Jallal $8,008,503
Fiscal 2021
Executive Total
Bahija Jallal $34,783,285

Executive changes

Person Change Filed
David Berman
“Dr. Berman’s decision to resign was not the result of any disagreement between Dr. Berman and the Company or any matter relating to the Company’s operations, policies, or practices.”
Resigned 2026-01-30
Tina St. Leger
“Ms. St. Leger’s decision to resign was not the result of any disagreement between Ms. St. Leger and the Company or any matter relating to the Company’s operations, policies, or practices.”
Resigned 2025-11-28
Ranjeev Krishana
“Mr. Krishana’s decision to resign was not the result of any disagreement between Mr. Krishana and the Company, management of the Company, or any other member of the Board on any matter relating to the Company’s operations, policies, or practices.”
Resigned 2025-11-28
William Pao, M.D., Ph.D. Appointed 2025-02-26
Travis Coy Resigned 2025-01-02
Travis Coy Appointed 2025-01-02
Brian Di Donato
“Mr. Di Donato’s resignation was not because of any disagreement with the Company on any matter relating to the Company’s financial statements, internal controls, operations, policies or practices, including accounting principles and practices.”
Resigned 2024-08-29
Ranjeev Krishana Appointed 2024-05-28

Leadership

Key facts CIK 1671927 CUSIP 45258D105 13F (30d) 150 filings 122 filers Visit website Investor relations